Finweek English Edition - - INVESTMENT -

Ci­pla In­dia fi­nally got its deal with Ci­pla Med­pro back on track, with a pro­vi­sional of­fer to ac­quire 51% of the com­pany at 855c/share. The big ben­e­fit here is that this firmly ce­ments the re­la­tion­ship be­tween the two par­ties and as such is a good deal for share­hold­ers – but is the 855c/share a fair price?The com­pany has been hav­ing a tough time of it re­cently and the most re­cent news is the sud­den de­par­ture of the CFO, which asks some ques­tions about this pro­posed deal. The board will of course get an in­de­pen­dent re­view of the fair­ness of the of­fer and as men­tioned even if the of­fer price is a lit­tle light, likely it’s worth it to ce­ment the re­la­tion­ship be­tween Ci­pla SA and Ci­pla In­dia.

Newspapers in English

Newspapers from South Africa

© PressReader. All rights reserved.